Andreazza AC, Shao L, Wang JF, Young LT. Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry. 2010;67:360–8.
Article CAS PubMed Google Scholar
Bamne MN, Talkowski ME, Moraes CT, Manuck SB, Ferrell RE, Chowdari KV, et al. Systematic association studies of mitochondrial DNA variations in schizophrenia: focus on the ND5 gene. Schizophr Bull. 2008;34:458–65.
Das SC, Hjelm BE, Rollins BL, Sequeira A, Morgan L, Omidsalar AA, et al. Mitochondria DNA copy number, mitochondria DNA total somatic deletions, Complex I activity, synapse number, and synaptic mitochondria number are altered in schizophrenia and bipolar disorder. Translational psychiatry. 2022;12:353.
Article CAS PubMed PubMed Central Google Scholar
Devlin B, Roeder K, Wasserman L. Genomic control, a new approach to genetic-based association studies. Theor Popul Biol. 2001;60:155–66.
Article CAS PubMed Google Scholar
Frye MA, Ryu E, Nassan M, Jenkins GD, Andreazza AC, Evans JM, et al. Mitochondrial DNA sequence data reveals association of haplogroup U with psychosis in bipolar disorder. J Psychiatr Res. 2017;84:221–6.
Giménez-Palomo A, Dodd S, Anmella G, Carvalho AF, Scaini G, Quevedo J, et al. The role of Mitochondria in Mood Disorders: from physiology to pathophysiology and to treatment. Front Psychiatry. 2021;12:546801.
Article PubMed PubMed Central Google Scholar
Gonçalves VF, Giamberardino SN, Crowley JJ, Vawter MP, Saxena R, Bulik CM, et al. Examining the role of common and rare mitochondrial variants in schizophrenia. PLoS ONE. 2018;13:e0191153.
Article PubMed PubMed Central Google Scholar
Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet (London England). 2016;387:1561–72.
Hagen CM, Gonçalves VF, Hedley PL, Bybjerg-Grauholm J, Bækvad-Hansen M, Hansen CS, et al. Schizophrenia-associated mt-DNA SNPs exhibit highly variable haplogroup affiliation and nuclear ancestry: bi-genomic dependence raises major concerns for link to disease. PLoS ONE. 2018;13:e0208828.
Article CAS PubMed PubMed Central Google Scholar
Holper L, Ben-Shachar D, Mann JJ. Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. 2019;44:837–49.
Article CAS PubMed Google Scholar
Hudson G, Gomez-Duran A, Wilson IJ, Chinnery PF. Recent mitochondrial DNA mutations increase the risk of developing common late-onset human diseases. PLoS Genet. 2014;10:e1004369.
Article PubMed PubMed Central Google Scholar
Inada T, Inagaki A. Psychotropic dose equivalence in Japan. J Neuropsychiatry Clin Neurosci. 2015;69:440–7.
Kataoka Y, Shimada T, Koide Y, Okubo H, Uehara T, Shioiri T, et al. Differences in executive function among patients with schizophrenia, their unaffected first-degree relatives and healthy participants. Int J Neuropsychopharmacol. 2020;23:731–7.
Article PubMed PubMed Central Google Scholar
Kato T, Kunugi H, Nanko S, Kato N. Association of bipolar disorder with the 5178 polymorphism in mitochondrial DNA. Am J Med Genet. 2000;96:182–6.
Article CAS PubMed Google Scholar
Matsuoka K, Uno M, Kasai K, Koyama K, Kim Y. Estimation of premorbid IQ in individuals with Alzheimer’s disease using japanese ideographic script (Kanji) compound words: japanese version of National Adult Reading Test. J Neuropsychiatry Clin Neurosci. 2006;60:332–9.
McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R. Cardno a the heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry. 2003;60:497–502.
McMahon FJ, Stine OC, Meyers DA, Simpson SG, DePaulo. JR patterns of maternal transmission in bipolar affective disorder. Am J Hum Genet. 1995;56:1277–86.
CAS PubMed PubMed Central Google Scholar
Morris G, Walder KR, Berk M, Marx W, Walker AJ, Maes M, et al. The interplay between oxidative stress and bioenergetic failure in neuropsychiatric illnesses: can we explain it and can we treat it? Mol Biol Rep. 2020;47:5587–620.
Article CAS PubMed Google Scholar
Mosquera-Miguel A, Torrell H, Abasolo N, Arrojo M, Paz E, Ramos-Ríos R, et al. No evidence that major mtDNA european haplogroups confer risk to schizophrenia. Am J Med Genet Part B Neuropsychiatric genetics: official publication Int Soc Psychiatric Genet. 2012;159b:414–21.
Mullins N, Forstner AJ, O’Connell KS, Coombes B, Coleman JRI, Qiao Z, et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat Genet. 2021;53:817–29.
Article CAS PubMed PubMed Central Google Scholar
Munakata K, Tanaka M, Mori K, Washizuka S, Yoneda M, Tajima O, et al. Mitochondrial DNA 3644T–>C mutation associated with bipolar disorder. Genomics. 2004;84:1041–50.
Article CAS PubMed Google Scholar
Nishimura Y, Kanda Y, Sone H, Aoyama H. Oxidative stress as a common key event in Developmental Neurotoxicity. Oxidative Med Cell Longev. 2021;2021:6685204.
Ohi K, Takai K, Kuramitsu A, Sugiyama S, Shioiri T, Common Brain. Cortical Abnormality in Smoking Behavior and Bipolar Disorder: Discriminant Analysis Using Cortical Thickness and Surface Area. Cerebral cortex (New York, N.Y.: 1991) 2022c.
Ohi K, Shimada T, Nemoto K, Kataoka Y, Yasuyama T, Kimura K, et al. Cognitive clustering in schizophrenia patients, their first-degree relatives and healthy subjects is associated with anterior cingulate cortex volume. NeuroImage Clin. 2017;16:248–56.
Article PubMed PubMed Central Google Scholar
Ohi K, Shimada T, Kataoka Y, Koide Y, Yasuyama T, Uehara T, et al. Intelligence decline between present and premorbid IQ in schizophrenia: Schizophrenia non-affected relative project (SNARP). Eur neuropsychopharmacology: J Eur Coll Neuropsychopharmacol. 2019;29:653–61.
Ohi K, Nishizawa D, Muto Y, Sugiyama S, Hasegawa J, Soda M, et al. Polygenic risk scores for late smoking initiation associated with the risk of schizophrenia. NPJ schizophrenia. 2020a;6:36.
Article PubMed PubMed Central Google Scholar
Ohi K, Nishizawa D, Shimada T, Kataoka Y, Hasegawa J, Shioiri T, et al. Polygenetic risk scores for Major Psychiatric Disorders among Schizophrenia Patients, their first-degree relatives, and healthy participants. Int J Neuropsychopharmacol. 2020b;23:157–64.
Article PubMed PubMed Central Google Scholar
Ohi K, Nishizawa D, Sugiyama S, Takai K, Kuramitsu A, Hasegawa J, et al. Polygenic risk scores differentiating Schizophrenia from Bipolar Disorder are Associated with Premorbid Intelligence in Schizophrenia Patients and healthy subjects. Int J Neuropsychopharmacol. 2021;24:562–9.
Article PubMed PubMed Central Google Scholar
Ohi K, Ishibashi M, Torii K, Hashimoto M, Yano Y, Shioiri T. Differences in subcortical brain volumes among patients with schizophrenia and bipolar disorder and healthy controls. J Psychiatry Neurosci. 2022a;47:E77–E85.
Article PubMed PubMed Central Google Scholar
Ohi K, Nishizawa D, Sugiyama S, Takai K, Fujikane D, Kuramitsu A et al. Cognitive performances across individuals at high genetic risk for schizophrenia, high genetic risk for bipolar disorder, and low genetic risks: a combined polygenic risk score approach. Psychol Med 2022b:1–10.
Ruderfer D, Ripke S, McQuillin A, Boocock J, Stahl E, Pavlides J, et al. Genomic dissection of bipolar disorder and Schizophrenia, including 28 subphenotypes. Cell. 2018;173:1705–15. e1716.
Article CAS PubMed Central Google Scholar
Ryu E, Nassan M, Jenkins GD, Armasu SM, Andreazza A, McElroy SL, et al. A genome-wide search for bipolar disorder risk loci modified by mitochondrial genome variation. Mol neuropsychiatry. 2018;3:125–34.
Saha S, Chant D, Welham J, McGrath. J a systematic review of the prevalence of schizophrenia. PLoS Med. 2005;2:e141.
Article PubMed PubMed Central Google Scholar
Sequeira A, Martin MV, Rollins B, Moon EA, Bunney WE, Macciardi F, et al. Mitochondrial mutations and polymorphisms in psychiatric disorders. Front Genet. 2012;3:103.
Article PubMed PubMed Central Google Scholar
Smeland OB, Bahrami S, Frei O, Shadrin A, O’Connell K, Savage J, et al. Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence. Mol Psychiatry. 2020;25:844–53.
Article CAS PubMed Google Scholar
Steckert AV, Valvassori SS, Moretti M, Dal-Pizzol F, Quevedo J. Role of oxidative stress in the pathophysiology of bipolar disorder. Neurochem Res. 2010;35:1295–301.
Article CAS PubMed Google Scholar
Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003;60:1187–92.
Thorburn DR, Rahman J, Rahman S. Mitochondrial DNA-Associated Leigh Syndrome and NARP. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews(®). Seattle (WA): University of Washington, Seattle; 1993. Copyright. © 1993–2022, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.
Torrell H, Montaña E, Abasolo N, Roig B, Gaviria AM, Vilella E, et al. Mitochondrial DNA (mtDNA) in brain samples from patients with major psychiatric disorders: gene expression profiles, mtDNA content and presence of the mtDNA common deletion. Am J Med Genet Part B Neuropsychiatric genetics: official publication Int Soc Psychiatric Genet. 2013;162b:213–23.
Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604:502–8.
留言 (0)